Literature DB >> 22841552

Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase.

Erin Noble1, Andrew Cox, Jerome Deval, Baek Kim.   

Abstract

The influenza A polymerase is a heterotrimer which transcribes viral mRNAs and replicates the viral genome. To initiate synthesis of mRNA, the polymerase binds a host pre-mRNA and cleaves a short primer downstream of the 5' end cap structure. The N-terminal domain of PA has been demonstrated to have endonuclease activity in vitro. Here we sought to better understand the biochemical nature of the PA endonuclease by developing an improved assay using full-length PA protein. This full-length protein is active against both RNA and DNA in a cap-independent manner and can use several different divalent cations as cofactors, which affects the secondary structure of the full-length PA. Our in vitro assay was also able to demonstrate the minimal substrate size and sequence selectivity of the PA protein, which is crucial information for inhibitor design. Finally, we confirmed the observed endonuclease activity of the full-length PA with a FRET-based assay.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841552      PMCID: PMC3647620          DOI: 10.1016/j.virol.2012.07.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template.

Authors:  L L Poon; D C Pritlove; E Fodor; G G Brownlee
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Metal ion catalysis of RNA cleavage by the influenza virus endonuclease.

Authors:  L Doan; B Handa; N A Roberts; K Klumpp
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

3.  Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.

Authors:  J C Hastings; H Selnick; B Wolanski; J E Tomassini
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit.

Authors:  Thibaut Crépin; Alexandre Dias; Andrés Palencia; Christopher Swale; Stephen Cusack; Rob W H Ruigrok
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo.

Authors:  A R Beaton; R M Krug
Journal:  Nucleic Acids Res       Date:  1981-09-11       Impact factor: 16.971

6.  RNAstructure: software for RNA secondary structure prediction and analysis.

Authors:  Jessica S Reuter; David H Mathews
Journal:  BMC Bioinformatics       Date:  2010-03-15       Impact factor: 3.169

7.  Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model.

Authors:  J Kim; C Lee; Y Chong
Journal:  SAR QSAR Environ Res       Date:  2009       Impact factor: 3.000

8.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.

Authors:  Alexandre Dias; Denis Bouvier; Thibaut Crépin; Andrew A McCarthy; Darren J Hart; Florence Baudin; Stephen Cusack; Rob W H Ruigrok
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

9.  Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.

Authors:  Puwei Yuan; Mark Bartlam; Zhiyong Lou; Shoudeng Chen; Jie Zhou; Xiaojing He; Zongyang Lv; Ruowen Ge; Xuemei Li; Tao Deng; Ervin Fodor; Zihe Rao; Yingfang Liu
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

10.  The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit.

Authors:  Birgit G Bradel-Tretheway; Z Kelley; Shikha Chakraborty-Sett; Toru Takimoto; Baek Kim; Stephen Dewhurst
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more
  21 in total

1.  GTP is the primary activator of the anti-HIV restriction factor SAMHD1.

Authors:  Sarah M Amie; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

2.  Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease.

Authors:  Annelies Stevaert; Roberto Dallocchio; Alessandro Dessì; Nicolino Pala; Dominga Rogolino; Mario Sechi; Lieve Naesens
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  The N-terminal domain of PA from bat-derived influenza-like virus H17N10 has endonuclease activity.

Authors:  Boris Tefsen; Guangwen Lu; Yaohua Zhu; Joel Haywood; Lili Zhao; Tao Deng; Jianxun Qi; George F Gao
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

4.  The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA.

Authors:  Laura Bavagnoli; Stefano Cucuzza; Giulia Campanini; Francesca Rovida; Stefania Paolucci; Fausto Baldanti; Giovanni Maga
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

5.  Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Authors:  Shuofeng Yuan; Naru Zhang; Kailash Singh; Huiping Shuai; Hin Chu; Jie Zhou; Billy K C Chow; Bo-Jian Zheng
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

6.  3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease.

Authors:  Hye Yeon Sagong; Ajit Parhi; Joseph D Bauman; Disha Patel; R S K Vijayan; Kalyan Das; Eddy Arnold; Edmond J LaVoie
Journal:  ACS Med Chem Lett       Date:  2013-05-07       Impact factor: 4.345

7.  Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

Authors:  Min-Suk Song; Gyanendra Kumar; William R Shadrick; Wei Zhou; Trushar Jeevan; Zhenmei Li; P Jake Slavish; Thomas P Fabrizio; Sun-Woo Yoon; Thomas R Webb; Richard J Webby; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

Review 8.  New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.

Authors:  Grant Beyleveld; Kris M White; Juan Ayllon; Megan L Shaw
Journal:  Antiviral Res       Date:  2013-08-06       Impact factor: 5.970

9.  Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors.

Authors:  Joseph D Bauman; Disha Patel; Steven F Baker; R S K Vijayan; Amy Xiang; Ajit K Parhi; Luis Martínez-Sobrido; Edmond J LaVoie; Kalyan Das; Eddy Arnold
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

10.  Anti-influenza activity of c60 fullerene derivatives.

Authors:  Masaki Shoji; Etsuhisa Takahashi; Dai Hatakeyama; Yuma Iwai; Yuka Morita; Riku Shirayama; Noriko Echigo; Hiroshi Kido; Shigeo Nakamura; Tadahiko Mashino; Takeshi Okutani; Takashi Kuzuhara
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.